Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wahren

Showing results (71-80 of 402) with videos related to

Pageof 41
Sort By:
Antiviral Research|April 1, 1985
Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cellsJ Harmenberg, G Abele, B Wahren
Lakartidningen|June 28, 1978
[Symptomatic CMV infection in previously healthy individuals]G Stiernstedt, G Sterner, B Wahren
International Journal of Cancer|January 15, 1980
Distribution of tumor-associated antigen CEA and cross-reacting NCA in fetal organsH Gadler, K Bremme, B Wahren
Nature|April 8, 1993
Properties of an HIV 'vaccine'B Wahren, E Sandström, H Wigzell
Clinical and Diagnostic Laboratory Immunology|May 1, 1996
Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodiesM Levi, U Rudén, B Wahren
Journal of Medical Virology|January 1, 1982
Adsorption of purified human cytomegalovirus and induction of early antigens in different cellsL Einhorn, H Gadler, B Wahren
Biochimica Et Biophysica Acta|February 26, 1982
Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular originB Eriksson, B Oberg, B Wahren
Intervirology|January 1, 1980
Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosineJ Harmenberg, B Wahren, B Oberg
Journal of Medical Virology|January 1, 1981
Antibody response to cytomegalovirus: a comparison between adult patients with neurological disease and uncomplicated infectionM Granström, A Linde, B Wahren
Clinical and Experimental Immunology|May 1, 1979
Elevated serum levels of a biliary glycoprotein (BGP I) in patients with liver or biliary tract diseaseT Svenberg, B Wahren, S Hammarström
Pageof 41

Showing results (71-80 of 402) with videos related to

Sort By:
Pageof 41
Antiviral Research|April 1, 1985
Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cellsJ Harmenberg, G Abele, B Wahren
Lakartidningen|June 28, 1978
[Symptomatic CMV infection in previously healthy individuals]G Stiernstedt, G Sterner, B Wahren
International Journal of Cancer|January 15, 1980
Distribution of tumor-associated antigen CEA and cross-reacting NCA in fetal organsH Gadler, K Bremme, B Wahren
Nature|April 8, 1993
Properties of an HIV 'vaccine'B Wahren, E Sandström, H Wigzell
Clinical and Diagnostic Laboratory Immunology|May 1, 1996
Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodiesM Levi, U Rudén, B Wahren
Journal of Medical Virology|January 1, 1982
Adsorption of purified human cytomegalovirus and induction of early antigens in different cellsL Einhorn, H Gadler, B Wahren
Biochimica Et Biophysica Acta|February 26, 1982
Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular originB Eriksson, B Oberg, B Wahren
Intervirology|January 1, 1980
Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosineJ Harmenberg, B Wahren, B Oberg
Journal of Medical Virology|January 1, 1981
Antibody response to cytomegalovirus: a comparison between adult patients with neurological disease and uncomplicated infectionM Granström, A Linde, B Wahren
Clinical and Experimental Immunology|May 1, 1979
Elevated serum levels of a biliary glycoprotein (BGP I) in patients with liver or biliary tract diseaseT Svenberg, B Wahren, S Hammarström
Pageof 41